Back to Bedrocan® or All Bud/Flower

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Comparative Values)

Alpha-Pinene8.08%Pine/Sharp156℃
Beta-Pinene4.04%Pine/Herbal165℃
Myrcene70.71%Herbal/Musk166-168℃
Humulene4.04%Woody/Earthy107℃
Ocimene5.05%Herbal/Sweet174-175℃
Terpinolene8.08%Floral/Herbal185℃

MedBud currently tracks 16 common terpenes, more will be added.

Dosing Look-Up Table (Estimated)

0.01/g0.63/mg THC0.8/mg CBD
0.05/g3.15/mg THC4/mg CBD
0.1/g6.3/mg THC8/mg CBD
0.15/g9.45/mg THC12/mg CBD
0.2/g12.6/mg THC16/mg CBD
0.25/g15.75/mg THC20/mg CBD
0.3/g18.9/mg THC24/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
Netherlands Bedrocan®
Designation
Bediol T6:C8
Cultivar/Strain
Elida
Classification
Sativa
Chemotype
Type II: THC/CBD Mix
Flower Provided
Granulated Flower
THC Potential Range (±10%)
5.67-6.93%
CBD Potential Range (±10%)
8%
0
Cultivated/Produced by
Netherlands Bedrocan®
Cultivated in
Flag of Netherlands Netherlands
Irradiation
Gamma-Irradiated
Imported as
Schedule II: Finished Product
Packaged in
Flag of Netherlands Netherlands

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: No Importer

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Dispensing Patient Pharmacies

Product DescriptionPatient Reviews

About Elida

EliSativa

A proprietary strain from Bedrocan BV.

Proprietary Strain

Little is known about this strain other than it being bred in-house by the cultivator. While patient rumours persist over the origins of this strain, none are currently confirmed.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

Netherlands About Bedrocan B.V.

Bedrocan® Logo

Bedrocan strives to develop and deliver the full medical potential of the cannabis plant to those in need worldwide, aiming to bridge the gap between patients’ needs and the regulatory demands of modern medicine by using rigorous scientific methods and testing to achieve safety and efficacy.

Bedrocan is an EU-GMP certified supplier of pharmaceutical grade cannabis to the Dutch Office of Medicinal Cannabis (OMC). Our high quality products are used as pharmaceutical raw materials and active pharmaceutical ingredients (APIs). We operate two indoor cultivation facilities and an R&D facility in the Netherlands.

Bedrocan strives to develop and deliver the full medical potential of the cannabis plant to those in need worldwide.

We strongly believe herbal cannabis can, and should, meet all of the existing regulations for medicines. At Bedrocan we strive to achieve the registration of herbal cannabis as an official medicine through a regulatory process that is acceptable to patients, regulators, and healthcare professionals.

Bedrocan aims to bridge the gap between patients’ needs and the regulatory demands of modern medicine by using rigorous scientific methods and testing to achieve safety and efficacy. We do this:

  • through an active research program and a commitment to sharing our knowledge through scientific publications,
  • by offering pharmaceutical quality cannabis under nationally and federally regulated medicinal cannabis programmes worldwide.
bedrocan.com

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)